Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women-Reference-Cited by-同舟云学术

Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women

Published:2012-06-01 Issue:6 Volume:97 Page:2027-2032
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Arasu Aarthi¹,Cawthon Peggy M.²³,Lui Li-Yung²³,Do Thy P.⁴,Arora Puneet S.⁴,Cauley Jane A.⁵,Ensrud Kristine E.⁶,Cummings Steven R.²,

Affiliation:

1. Department of Medicine (A.A.), California, 94107

2. University of California, San Francisco, and San Francisco Coordinating Center (P.M.C., L.-Y.L., S.R.C.), California, 94107

3. California Pacific Medical Center Research Institute (P.M.C, L.-Y.L., S.R.C.), San Francisco, California, 94107

4. Amgen Inc., (T.P.D., P.S.A.) Thousand Oaks, California 91320

5. Department of Epidemiology (J.A.C.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15260

6. Minneapolis Veterans Affairs Medical Center (K.E.E.), University of Minnesota, Minneapolis, Minnesota 55417

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/97/6/2027/10747227/jcem2027.pdf

Reference20 articles.

1. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture.;Johnell;Osteoporos Int,2004

2. Nonresponders to osteoporosis therapy.;Lewiecki;J Clin Densitom,2003

3. Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial.;Chapurlat;Osteoporos Int,2005

4. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.;Li;J Biol Chem,2005

5. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.;Semënov;J Biol Chem,2005

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interrelationships among metabolic syndrome, bone-derived cytokines, and the most common metabolic syndrome-related diseases negatively affecting bone quality;Diabetology & Metabolic Syndrome;2024-09-06

2. The Relationship between Sclerostin and Kidney Transplantation Mineral Bone Disorders: A Molecule of Controversies;Calcified Tissue International;2024-07-30

3. Osteoporosis and Fracture Risk among Older US Asian Adults;Current Osteoporosis Reports;2023-08-05

4. All-trans Retinoic Acid and Beta-Carotene Increase Sclerostin Production in C2C12 Myotubes;Biomedicines;2023-05-12

5. Relationships between sclerostin and morphometric vertebral fractures, bone mineral density, and bone microarchitecture in postmenopausal women;Archives of Osteoporosis;2023-04-29